Bank of America’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.59M Sell
1,270,607
-34,380
-3% -$70K ﹤0.01% 3816
2025
Q1
$2.13M Buy
1,304,987
+664,000
+104% +$1.08M ﹤0.01% 3878
2024
Q4
$1.17M Buy
640,987
+584,521
+1,035% +$1.07M ﹤0.01% 4125
2024
Q3
$326K Buy
56,466
+18,109
+47% +$105K ﹤0.01% 4902
2024
Q2
$310K Buy
38,357
+800
+2% +$6.46K ﹤0.01% 4842
2024
Q1
$521K Buy
37,557
+7,995
+27% +$111K ﹤0.01% 4531
2023
Q4
$181K Sell
29,562
-4,950
-14% -$30.3K ﹤0.01% 5208
2023
Q3
$161K Sell
34,512
-21,318
-38% -$99.5K ﹤0.01% 5149
2023
Q2
$299K Sell
55,830
-237,556
-81% -$1.27M ﹤0.01% 4770
2023
Q1
$2.89M Buy
293,386
+87,515
+43% +$861K ﹤0.01% 3447
2022
Q4
$3.85M Buy
205,871
+65,839
+47% +$1.23M ﹤0.01% 3120
2022
Q3
$2.9M Buy
140,032
+55,271
+65% +$1.14M ﹤0.01% 3341
2022
Q2
$1.76M Sell
84,761
-36,117
-30% -$750K ﹤0.01% 3815
2022
Q1
$5.21M Buy
120,878
+67,303
+126% +$2.9M ﹤0.01% 3108
2021
Q4
$3.21M Buy
53,575
+37,815
+240% +$2.27M ﹤0.01% 3503
2021
Q3
$1.35M Sell
15,760
-7,555
-32% -$649K ﹤0.01% 4102
2021
Q2
$2.59M Sell
23,315
-8,691
-27% -$967K ﹤0.01% 3542
2021
Q1
$3.56M Buy
32,006
+23,878
+294% +$2.66M ﹤0.01% 3290
2020
Q4
$863K Sell
8,128
-84,151
-91% -$8.93M ﹤0.01% 3979
2020
Q3
$12.8M Buy
92,279
+73,913
+402% +$10.3M ﹤0.01% 1846
2020
Q2
$5.94M Buy
18,366
+11,618
+172% +$3.76M ﹤0.01% 2414
2020
Q1
$602K Buy
6,748
+4,001
+146% +$357K ﹤0.01% 3883
2019
Q4
$109K Sell
2,747
-3,431
-56% -$136K ﹤0.01% 5150
2019
Q3
$151K Buy
6,178
+1
+0% +$24 ﹤0.01% 5041
2019
Q2
$217K Sell
6,177
-9,143
-60% -$321K ﹤0.01% 4836
2019
Q1
$686K Buy
15,320
+10,776
+237% +$483K ﹤0.01% 4138
2018
Q4
$217K Sell
4,544
-656
-13% -$31.3K ﹤0.01% 4755
2018
Q3
$348K Sell
5,200
-4,355
-46% -$291K ﹤0.01% 4492
2018
Q2
$449K Buy
9,555
+2,562
+37% +$120K ﹤0.01% 4298
2018
Q1
$395K Buy
6,993
+4,535
+184% +$256K ﹤0.01% 4318
2017
Q4
$122K Sell
2,458
-263
-10% -$13.1K ﹤0.01% 4884
2017
Q3
$207K Buy
2,721
+1,495
+122% +$114K ﹤0.01% 4612
2017
Q2
$116K Sell
1,226
-1,129
-48% -$107K ﹤0.01% 4812
2017
Q1
$188K Buy
2,355
+301
+15% +$24K ﹤0.01% 4632
2016
Q4
$171K Buy
2,054
+1,243
+153% +$103K ﹤0.01% 4642
2016
Q3
$91K Sell
811
-958
-54% -$107K ﹤0.01% 4721
2016
Q2
$196K Buy
1,769
+1,356
+328% +$150K ﹤0.01% 4459
2016
Q1
$44K Sell
413
-1,179
-74% -$126K ﹤0.01% 5019
2015
Q4
$128K Buy
1,592
+1,253
+370% +$101K ﹤0.01% 4678
2015
Q3
$23K Sell
339
-5,363
-94% -$364K ﹤0.01% 5244
2015
Q2
$558K Buy
5,702
+4,817
+544% +$471K ﹤0.01% 3730
2015
Q1
$87K Sell
885
-603
-41% -$59.3K ﹤0.01% 4435
2014
Q4
$164K Buy
1,488
+1,090
+274% +$120K ﹤0.01% 4269
2014
Q3
$47K Sell
398
-807
-67% -$95.3K ﹤0.01% 4880
2014
Q2
$157K Buy
1,205
+1,038
+622% +$135K ﹤0.01% 4363
2014
Q1
$26K Sell
167
-644
-79% -$100K ﹤0.01% 5024
2013
Q4
$113K Sell
811
-1,603
-66% -$223K ﹤0.01% 4494
2013
Q3
$240K Buy
2,414
+62
+3% +$6.16K ﹤0.01% 3951
2013
Q2
$90K Buy
+2,352
New +$90K ﹤0.01% 4818